Cambrooke Therapeutics
Health & Nutrition Products · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4 Copeland Dr, Ayer, Massachusetts, 0143...Phone Number
(508) 782-2300Website
www.cambrooke.comRevenue
$18 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Cambrooke Therapeutics
Ajinomoto Cambrooke is a global leader in advanced medical nutrition, dedicated to improving the lives of patients with therapeutic and chronic medical needs. The company develops, manufactures, and commercializes nutritional therapeutic options aimed at enhancing patient satisfaction and clinical outcomes across various diseases. Their product offerings include low protein foods, metabolic formulas, and ketogenic options, catering to individuals with specific dietary requirements. With a commitment to innovation and patient support, Ajinomoto Cambrooke strives to provide effective treatment solutions while allowing patients to maintain their daily lives.Explore more
Cambrooke Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cambrooke Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Cambrooke Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cambrooke Therapeutics is spiking on competitors!
Cambrooke Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Cambrooke Therapeutics has new funding data
Check if Cambrooke Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Cambrooke Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Cambrooke Therapeutics
Click to see if Cambrooke Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Cambrooke Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Cambrooke Therapeutics
Compare insights from companies similar to Cambrooke Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cambrooke Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cambrooke Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cambrooke Therapeutics.
Cambrooke Therapeutics financials insights
Gather financial insights about Cambrooke Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Unspecified
$8M
2020
Debt
$350K
Cambrooke Therapeutics Tech Stack
A closer look at the technologies used by Cambrooke Therapeutics
Most Recent Scoops
Project
A front-line source in Product Management has indicated that the organization is in the midst of initiatives related to application lifecycle management (ALM). Cambrooke Therapeutics Inc is currently evaluating Arena Solutions. The organization will be increasing investments and is expected to use a contingent workforce to support these efforts.
Spending/Investment, Application Development, Quality Assurance, Product Development, Contingent Workforce, Enterprise Architecture, Financial Planning, Product Management
Project
A front-line source in Product Management has indicated that the organization is in the midst of initiatives related to improving developer productivity. Cambrooke Therapeutics Inc is currently evaluating DataKitchen. The organization will be increasing investments and is expected to use a contingent workforce to support these efforts.
Spending/Investment, Product Development, Contingent Workforce, Financial Planning, Product Management, Workforce Management
Project
A front-line source in Product Management has indicated that the organization is in the midst of initiatives related to improving time to market. Cambrooke Therapeutics Inc is currently evaluating AppMaster. The organization will be increasing investments and is expected to use a contingent workforce to support these efforts.
Spending/Investment, Product Development, Contingent Workforce, Financial Planning, Product Management
Project
A front-line source in Product Management has indicated that the organization is in the midst of initiatives related to project management software. Cambrooke Therapeutics Inc is currently evaluating Airtable. The organization will be increasing investments and is expected to use a contingent workforce to support these efforts.
Spending/Investment, Contingent Workforce, Financial Planning, Product Management, Enterprise Software, Software, Workforce Management
Project
Spending/Investment, Analytics & Insights, Contingent Workforce, Financial Planning, Product Management, Document Management, Enterprise Software, Software, Logistics / Supply Chain
Cambrooke Therapeutics News & Media
Ajinomoto Cambrooke, Inc. continúa su expansión a nivel mundial con la adquisición de Nualtra Ltd.
AYER, Massachusetts--(BUSINESS WIRE)--Ajinomoto Cambrooke, Inc. ha adquirido Nualtra Limited, una empresa de nutrición médica que ofrece suplementos nutricionales orales para una mejor calidad de vida en el Reino Unido e Irlanda. Con esta adquisición, Cambrooke, innovador y líder mundial en nutrición terapéutica para problemas congénitos del metabolismo, dieta cetogénica terapéutica, desnutrición relacionada a enfermedades y, más recientemente, alergia grave a las proteínas, amplía la expansiónAjinomoto Cambrooke, Inc. Continua Sua Expansão em todo o Mundo com a Aquisição da Nualtra Ltd.
AYER, Massachusetts--(BUSINESS WIRE)--A Ajinomoto Cambrooke, Inc. adquiriu a Nualtra Limited, uma empresa de produtos de nutrição que fornece suplementos nutricionais orais para melhorar a vida no Reino Unido e na Irlanda. A Cambrooke, líder mundial e inovadora em nutrição terapêutica para erros inatos do metabolismo, dietoterapia cetogênica, desnutrição relacionada a doenças e, mais recentemente, alergia grave às proteínas, continua a expandir o seu portfólio de nutrição médica com esta aquisiAjinomoto Cambrooke, Inc. Continues to Expand Worldwide with the Acquisition of Nualtra Ltd.
AYER, Mass.--(BUSINESS WIRE)-- #Ajinomoto--Ajinomoto Cambrooke, Inc. has acquired Ireland-based Nualtra Limited, a medical nutrition company offering life-enhancing oral nutritional supplementsCambrooke Introduces Advanced New Hypoallergenic Amino Acid-based Formulas: EquaCare Jr.™ and Essential Care Jr.™
AYER, Mass.--(BUSINESS WIRE)--Ajinomoto Cambrooke, Inc., a U.S.-based therapeutic nutrition company and global provider of medical nutrition products, today introduced two essentially better hypoallergenic amino acid-based formulas for children: EquaCare Jr.™ and Essential Care Jr.™ Amino acids are the basic building blocks of protein. Specific reasons for use of amino acid-based formulas include severe food allergies and food protein intolerances as well as a range of gastrointestinal disorder
Read more news
Top Health & Nutrition Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cambrooke Therapeutics
Sign Up For FreeTo access detailed company insights
Ajinomoto Cambrooke is a global leader in advanced medical nutrition, dedicated to improving the lives of patients with therapeutic and chronic medical needs. The company develops, manufactures, and commercializes nutritional therapeutic options aimed at enhancing patient satisfaction and clinical outcomes across various diseases. Their product off... Read More
